WHO assesses Nipah virus spread risk as low following recent cases near India-Bangladesh border. Learn about the virus, symptoms, and fatality rate.

Geneva: The World Health Organization has said the risk of the deadly Nipah virus spreading was low after three cases of infection were recently confirmed in India and Bangladesh.
Nipah, which spreads from animals to humans, has no vaccine and a fatality rate ranging from 40 to 75 percent, according to the UN health body.
"In the past few weeks, three cases of Nipah -- two in India and one in Bangladesh -- made headlines and caused concern about a wider outbreak," WHO chief Tedros Adhanom Ghebreyesus told a press conference in Geneva on Wednesday.
WHO assessed the risk of spread of Nipah virus regionally and globally and found it low, he added.
Two cases of Nipah were confirmed last month in India's West Bengal state while one patient died in Bangladesh last week after contracting the virus.
Also Read: New Nipah virus vaccine proves safe, shows strong immune response: The Lancet
"The two outbreaks were not related, although both occurred along the India-Bangladesh border, and share some of the same ecological and cultural conditions, as well as populations of the species of fruit bat that are known to be the natural reservoir of Nipah virus," Tedros said.
Nipah was first identified in 1998 after it spread among pig farmers in Malaysia.
In India, the first Nipah outbreak was reported in West Bengal in 2001.
In 2018, at least 17 people died from Nipah in Kerala, and in 2023, two people died from the virus in the same southern Indian state.
Symptoms include intense fever, vomiting and a respiratory infection, but severe cases can involve seizures and brain inflammation that results in a coma.
AFP
Published: 12 Feb 2026, 11:50 am IST
Related Topics
Subscribe to our Newsletter
Get Latest Mathrubhumi Updates in English
Disclaimer: Kindly avoid objectionable, derogatory, unlawful and lewd comments, while responding to reports. Such comments are punishable under cyber laws. Please keep away from personal attacks. The opinions expressed here are the personal opinions of readers and not that of Mathrubhumi.

